Skip to main content
SpringerLink
Log in

Transfusion Medicine

  • Chapter
  • First Online:
Blood and Marrow Transplant Handbook

  • 1824 Accesses

Abstract

The hematopoietic stem cell transplant (HSCT) recipient has unique transfusion requirements before, during, and after transplantation. The main goals associated with the transfusion of blood products is are reducing the risk of alloimmunization and avoiding potentially fatal complications of transfusion-associated graft-versus-host disease or lung injury, as well as peri- and posttransplant hemolysis. Additionally, careful attention must be paid to decrease the risk of infection transmission and potential medical errors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  • Aung FM, Lichtiger B, Bassett R, Liu P, Alousi A, Bashier Q, et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol. 2013;160:798–805.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Boeckh M, Nichols W, Papanicolaou G, Rubin R, Wingard J, Zaia J. Cytomegalovirus in hematopoietic stem cell transplants: current status, known challenges, and future strategies. Bio Blood Marrow Transplant. 2003;9:543–58.

    Article  Google Scholar 

  • Booth GS, Gehrie EA, Bolan CD, Savani BN. Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Bio Blood Marrow Transplant. 2013;19:1152–8.

    Article  CAS  Google Scholar 

  • Federici AB, Vanelli C, Arrigoni L. Transfusion issues in cancer patients. Thromb Res. 2012;129:560–5.

    Article  Google Scholar 

  • Gajewski J, Petz L, Calhoun L, et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without post-transplant methotrexate. Blood. 1992;79:3076–85.

    CAS  PubMed  Google Scholar 

  • Gajewski J, Johnson V, Sandler G, Sayegh A, Klumpp T. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood. 2008;112:3036–47.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hirokawa M, Fukuda T, Oshaki K, Hidaka M, Ichinohe T, Iwato K. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors. Biol Blood Marrow Transplant. 2013;19:1026–32.

    Article  PubMed  Google Scholar 

  • Klumpp T. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant. 1991;8:159–70.

    CAS  PubMed  Google Scholar 

  • Lapierre V, Mahé C, Aupérin A, et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplant. 2005;80:314–9.

    Article  Google Scholar 

  • LaRoche V, Eastlund D, McCullough J. Review: immunohematologic aspects of allogeneic hematopoietic progenitor cell transplantation. Immunohematology. 2004;20:217–25.

    CAS  PubMed  Google Scholar 

  • Nevo S, Fuller A, Zahurak M, Hartley E, Borinsky M, Volgesang G. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 × 109 or 20 × 109/L. Transfusion. 2007;49:1700–9.

    Article  Google Scholar 

  • Petz LD. Immunohematologic problems associated with bone marrow transplantation. Transfusion Med Rev. 1987;1:85–100.

    Article  CAS  Google Scholar 

  • Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. SeminHematol. 2004;41(Supp 1):93–100.

    Google Scholar 

  • Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014;127:124–31.

    Article  CAS  PubMed  Google Scholar 

  • Stroncek D, McCullough J. Policies and procedures for the establishment of an allogeneic blood stem cell collection program. Transfus Med. 1997;7:77–87.

    Article  CAS  PubMed  Google Scholar 

  • Torbati SS, Schlesinger S, Niku D. Acute respiratory failure during routine blood transfusion: a case report and review of the literature. J Emerg Med. 46:341–4.

    Google Scholar 

  • Vlaar APJ, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet. 2013;382:984–94.

    Article  PubMed  Google Scholar 

  • Worel N, Grenix H, Keil F, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion. 2002;42:1293–301.

    Article  PubMed  Google Scholar 

  • Zhu KE, Li JP, Zhang T, Zhong J, Chen J. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. Hematology. 2007;12:117–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Hematologic Malignancies, Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, UHN 73C, 97239, Portland, OR, USA

    Susan Schubach Slater MN, FNP-BC & James Gajewski MD

Authors
  1. Susan Schubach Slater MN, FNP-BC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Gajewski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan Schubach Slater MN, FNP-BC .

Editor information

Editors and Affiliations

  1. Knight Cancer Institute Adult Blood and Marrow Stem Cell Transplant Program, Oregon Health & Science University Center for Hematologic Malignancies, Portland, Oregon, USA

    Richard T. Maziarz

  2. Knight Cancer Institute Adult Blood and Marrow Stem Cell Transplant Program, Oregon Health & Science University Center for Hematologic Malignancies, Portland, Oregon, USA

    Susan Schubach Slater

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Slater, S., Gajewski, J. (2015). Transfusion Medicine. In: Maziarz, R., Slater, S. (eds) Blood and Marrow Transplant Handbook. Springer, Cham. https://doi.org/10.1007/978-3-319-13832-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13832-9_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13831-2

  • Online ISBN: 978-3-319-13832-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation